Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

[11] Kunieda E(2008) capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses Ann Oncol 19 1242-1195

[12] Inomta T(2003)Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer Int J Radiat Oncol Biol Phys 55 1186-349

[13] Hayakawa K(2004)Defining prognosis for women with breast cancer and CNS metastases by HER2 status Clin Oncol 16 345-2743

[14] Katoh N(2006)Determinants and prognoses of locoregional and distant progression in breast cancer N Engl J Med 355 2733-2116

[15] Kobashi G(2005)Brain metastases from breast cancer: identification of a high risk group J Clin Oncol 23 2114-530

[16] Bartsch R(2008)Lapatinib plus capecitabine for HER2-positive advanced breast cancer Breast Cancer Res Treat 111 523-585

[17] De Vries C(1999)Survival after brain metastases from breast cancer in the trastuzumab era Eur J Cancer 35 580-3617

[18] Pluschnig U(2004)Brain metastases in breast cancer: prognostic factors and management J Clin Oncol 22 3608-1999

[19] Dubsky P(2008)Brain metastases in breast cancer: prognostic factors and management J Clin Oncol 26 1993-1459

[20] Bago-Horvath Z(2009)CNS metastases in breast cancer Clin Cancer Res 15 1452-1655

[11] Kunieda E(2008) capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses Ann Oncol 19 1242-1195

[12] Inomta T(2003)Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer Int J Radiat Oncol Biol Phys 55 1186-349

[13] Hayakawa K(2004)Defining prognosis for women with breast cancer and CNS metastases by HER2 status Clin Oncol 16 345-2743

[14] Katoh N(2006)Determinants and prognoses of locoregional and distant progression in breast cancer N Engl J Med 355 2733-2116

[15] Kobashi G(2005)Brain metastases from breast cancer: identification of a high risk group J Clin Oncol 23 2114-530

[16] Bartsch R(2008)Lapatinib plus capecitabine for HER2-positive advanced breast cancer Breast Cancer Res Treat 111 523-585

[17] De Vries C(1999)Survival after brain metastases from breast cancer in the trastuzumab era Eur J Cancer 35 580-3617

[18] Pluschnig U(2004)Brain metastases in breast cancer: prognostic factors and management J Clin Oncol 22 3608-1999

[19] Dubsky P(2008)Brain metastases in breast cancer: prognostic factors and management J Clin Oncol 26 1993-1459

[20] Bago-Horvath Z(2009)CNS metastases in breast cancer Clin Cancer Res 15 1452-1655